manganese-hydroxypropyl-tetraacetic acid

Mn2+ ions chelated to 1,3-diamino-propanol-N,N,N'N'-tetraacetic acid; an MR contrast agent with potential for detecting differences in myocardial blood flow; structure of HPTA in first source

Also Known As:

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Ahlström, Håkan: 1 article (10/2006)
2.	Bjerner, Tomas: 1 article (10/2006)
3.	Eriksson, Rolf: 1 article (10/2006)
4.	Johansson, Lars: 1 article (10/2006)
5.	Karlsson, Jan Olof G: 1 article (10/2006)

Related Diseases

1.

Body Weight (Weight, Body) 10/01/2006 - "MnHPTA at a dose of 25 micromol/kg body weight (b.w.) has the potential to detect perfusion differences in myocardium. " 10/01/2006 - "A difference of approximately 0.1 sec-1 in the R1 increase between rest and stress still remained 31 minutes after administration of 25 micromol MnHPTA/kg body weight. " 10/01/2006 - "R1 in the myocardium was calculated from MR signal intensity measurements in 18 pigs after intravenous injection of 5, 15, or 25 micromol MnHPTA/kg body weight. "

Related Therapies and Procedures

1.	Intravenous Injections